Aker Biomarine Asa · OSL:AKBM
Aker Biomarine Asa — Handelsbanken Nordic Mid/Small Cap Seminar 2021
15 slides from Aker Biomarine Asa's conference presentation, Jun 2, 2021
Slide 1: Presentation at the Handelsbanken Nordic Mid/Small Cap Seminar
Presentation at the Handelsbanken Nordic Mid/Small Cap Seminar 2 June 2021 Q3 2020 PRESENTATION Matts Johansen, CEO Katrine Klaveness, CFO 30 OCTOBER 2020 1
Slide 2: Important Notice
Important Notice This presentation has been prepared by Aker BioMarine ASA (the "Company"). The presentation does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any securities of the Company or a
Slide 3: Our story in a nutshell
Our story in a nutshell #1 246 289 154 125 2017 2018 2019 2020 Global krill harvester and High growth top line Best-in-class human, aqua, krill oil producer trajectory pet ingredients Vertically integrated business Sustainability at the High growth branded and model core private label supplements 3
Slide 4: Historically, we have delivered a strong financial trajectory
Historically, we have delivered a strong financial trajectory Top line evolution Profitability evolution Revenue Adjusted EBITDA and % margin (USDm) +2.3x (USDm) +4.3x 289 27.1% 25.6% 246 78 21.5% 154 14.1% 53 125 39 18 2017 2018 2019 2020 2017 2018 2019 2020 Geographic breakdown of revenue Product
Slide 5: Sustainable growth
Roadmap for long-term value creation ASPIRATION TO LIFT OPERATING MARGINS MAIN VALUE CREATION PILLARS Adj. EBITDA (USDm) ▪ Expand offshore harvesting capacity over the next few years and lower logistic cost with new service vessel Scale ▪ Substantial increase in onshore volumes ▪ Drive significant c
Slide 6: Sustainability is at the core and central to our way of doing business
Sustainability is at the core and central to our way of doing business 1 Sustainability framework anchored in UN SDGs Dedicated to improving Pioneering sustainable Ingredients for more Doing more and better human health fisheries sustainable aquaculture with less Contributing to science and innovati
Slide 7: Our vertically integrated business model enables significant scale and flexibility
Our vertically integrated business model enables significant scale and 2 flexibility… Harvesting Ingredient production R&D Krill oil production Sales & marketing Distribution & brands ~70% ofkrillglobal catch 30% CO emissions reduction in 2 ~160 published studies >80% ofoil global krill production ~
Slide 8: …resulting in substantial operating leverage and subsequent margin improvement potential
…resulting in substantial operating leverage and subsequent margin 2 improvement potential Offshore volumes & unit cost Onshore volumes & unit cost USD/MT USD/kg MT MT 2015 2016 2017 2018 2019 2020 2021E 2015 2016 2017 2018 2019 2020 2021E Note: Dotted line in offshore unit cost ($/MT) based on full
Slide 9: Our ingredients targeting disease prevention and promoting improvement in nutrition and health
Our ingredients targeting disease prevention and promoting 3 improvement in nutrition and health Preventative health ingredients Sustainable marine ingredients Active ingredients Share of 2020 Share of 2020 47% Share of 2020 51% 2% revenue revenue revenue ✓ Higher uptake in the body compared to fish
Slide 10: We have established significant expertise in both private label and own branded consumer supplements
We have established significant expertise in both private label and 4 own branded consumer supplements… Private label offering Brand offering Current retailers Revenue breakdown by customer 2020 Traditional Kori BRAND PROFIT MARKETING MARKETING RETAILER MARGIN RETAILER MARGIN New retailers AKER MARG
Slide 11: New product launches with corresponding margin potential
5 New product launches with corresponding margin potential Wide ranging innovation competencies… …targeting significant margin uplift potential New business model ™ Existing business Model Fundamental research Existing technical or New technical or knowledge competences knowledge competences Aqua fe
Slide 12: Lysoveta – a new business segment with broad application potential
Lysoveta – a new business segment with broad 5 application potential TAPPING INTO LARGE GLOBAL MARKETS WITH STRONG UNDERLYING DRIVERS PHARMA COLLARBORATION ▪ Aker BioMarine signed first pharmaceutical collaboration for Global markets by segments development of therapies based on LYSOVETA in January
Slide 13: INVI – addressing the large and growing protein market
5 INVI – adressing the large and growing protein market A UNIQUE PROTEIN INGREDIENT… …FOR THE GLOBAL PROTEIN MARKET Global retail protein market growth (all figures in $bn, Euromonitor) Forecast 40 36 38 34 34 32 12 30 12 27 12 11 12 12 11 10 EXCEPTIONAL PROTEIN EASY TO USE IN FINAL QUALITY APPLICAT
Slide 14: AION – a circularity solution provider offering Circularity as a Service
AION – a circularity solution provider offering Circularity as a 5 Service (CaaS) to the global recycled plastic market Service providers Integrated supply chain management Waste sources E2E ESG transparency reporting and traceability Logistics CaaS Customers (both upstream and downstream) Recovery
Slide 15: Thank You
Thank You ® AKER BIOMARINE
Aker BioMarine — Handelsbanken Nordic Mid/Small Cap Seminar 2021 on 6ix